The ADRB2 gene polymorphism was found to not only be associated with the susceptibility and severity of asthma, but also affected the therapeutic effect of bronchodilators, and thus specific genetic testing was recommended before certain medication treatments, so as to select the most suitable drug for pediatric asthma management (46, 47). The gene discussed is ADRB2; the disease is asthma.